Cargando…

A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation

We created a model to predict the development of liver carcinogenesis in patients with chronic hepatitis B (CHB) undergoing entecavir (ETV) therapy and to validate the accuracy using an independent dataset. A total of 328 CHB subjects were analyzed. Subjects were randomly assigned into 2 groups: the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishikawa, Hiroki, Nishijima, Norihiro, Enomoto, Hirayuki, Sakamoto, Azusa, Nasu, Akihiro, Komekado, Hideyuki, Nishimura, Takashi, Kita, Ryuichi, Kimura, Toru, Iijima, Hiroko, Nishiguchi, Shuhei, Osaki, Yukio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023923/ https://www.ncbi.nlm.nih.gov/pubmed/27603400 http://dx.doi.org/10.1097/MD.0000000000004832

Ejemplares similares

Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Hyponatremia in Hepatocellular Carcinoma Complicating with Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2015)

Clinical Implication of Performance Status in Patients with Hepatocellular Carcinoma Complicating with Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2015)

Transcatheter Arterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Clinical Outcome and Safety in Elderly Patients
por: Nishikawa, Hiroki, et al.
Publicado: (2014)

Long‐term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion
por: Takeda, Haruhiko, et al.
Publicado: (2019)

Relationship Between Hepatic Steatosis and the Elevation of Aminotransferases in HBV-Infected Patients With HBe-Antigen Negativity and a Low Viral Load
por: Enomoto, Hirayuki, et al.
Publicado: (2016)

Serum zinc concentration and quality of life in chronic liver diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Combined albumin-bilirubin grade and Mac-2 binding protein glycosylation isomer as a useful predictor in compensated liver cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2019)

Factors Associated With Protein-energy Malnutrition in Chronic Liver Disease: Analysis Using Indirect Calorimetry
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

Prognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus related liver disease
por: Takata, Ryo, et al.
Publicado: (2017)

Effect of psoas muscle mass after endoscopic therapy for patients with esophageal varices
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Changes in skeletal muscle mass after endoscopic treatment in patients with esophageal varices
por: Sakai, Yoshiyuki, et al.
Publicado: (2017)

Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort study
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Hepatoma-Derived Growth Factor: An Overview and Its Role as a Potential Therapeutic Target Molecule for Digestive Malignancies
por: Enomoto, Hirayuki, et al.
Publicado: (2020)

Dynapenia Rather Than Sarcopenia Is Associated with Metabolic Syndrome in Patients with Chronic Liver Diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Frailty and Sleep Disorder in Chronic Liver Diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Underwater endoscopic mucosal resection: a new endoscopic method for resection of rectal neuroendocrine tumor grade 1 (carcinoid) ≤ 10 mm in diameter
por: Yamashina, Takeshi, et al.
Publicado: (2018)

Cold snare polypectomy reduced delayed postpolypectomy bleeding compared with conventional hot polypectomy: a propensity score-matching analysis
por: Yamashina, Takeshi, et al.
Publicado: (2017)

Anthropometric Measurements and Frailty in Patients with Liver Diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Proposal of predictive model on survival in unresectable pancreatic cancer receiving systemic chemotherapy
por: Ishii, Noriko, et al.
Publicado: (2020)

Grip Strength: A Useful Marker for Composite Hepatic Events in Patients with Chronic Liver Diseases
por: Yoh, Kazunori, et al.
Publicado: (2020)

Two Cases of Hepatocellular Carcinoma Occurring Immediately after Direct-acting Antiviral Agents against Hepatitis C Virus
por: Nishijima, Norihiro, et al.
Publicado: (2018)

Entecavir-Associated Thrombocytopenia in a Decompensated Cirrhotic Patient: A Case Report and Literature Review
por: Fan, Xiaoli, et al.
Publicado: (2016)

Prognostic factors in patients with hepatitis B virus-related hepatocellular carcinoma undergoing nucleoside analog antiviral therapy
por: NISHIKAWA, HIROKI, et al.
Publicado: (2013)

Association between HBs Ag quantification and the risk of hepatocellular carcinoma in patients treated with tenofovir disoproxil fumarate or entecavir
por: Lim, Jung Hyun, et al.
Publicado: (2021)

Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy
por: Yoshida, Kanako, et al.
Publicado: (2021)

Dynamics of Genotypic Mutations of the Hepatitis B Virus Associated With Long-Term Entecavir Treatment Determined With Ultradeep Pyrosequencing: A Retrospective Observational Study
por: Zhang, Xia-Xia, et al.
Publicado: (2016)

Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma
por: NISHIKAWA, HIROKI, et al.
Publicado: (2012)

Meta-analysis of influences of Biejiajian Pill combined with entecavir on serum liver fibrosis markers of compensatory period of hepatitis b cirrhosis: Protocol of systematic review and meta-analysis
por: Zhang, Tianyao, et al.
Publicado: (2019)

Recanalization using a novel drill-shaped dilator for a severe pancreatic duct stricture and impacted pancreatic duct stone
por: Shiomi, Hideyuki, et al.
Publicado: (2023)

The Relationship between Controlling Nutritional (CONUT) Score and Clinical Markers among Adults with Hepatitis C Virus Related Liver Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2018)

Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma
por: Nishikawa, Hiroki, et al.
Publicado: (2011)

The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesis
por: Enomoto, Hirayuki, et al.
Publicado: (2017)

Long-term response on letrozole for gastric cancer: A case report
por: Iida, Yuuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aeam57oduvdj376mpriokkgm8l